Abstract | PURPOSE: METHODS: RESULTS: In the Wistar rats, both isoflurane (38 +/- 11%) and olprinone (40 +/- 11%) reduced infarct size as compared to the control group (59 +/- 8%). In the GK rats, olprinone (41 +/- 9%) but not isoflurane (53 +/- 11%) reduced infarct size as compared to the GK control group (58 +/- 14%). The beneficial effects of olprinone were blocked by LY (58 +/- 14%). In the Wistar rats, CHE, 5HD, and LY prevented isoflurane-induced reductions of infarct size. On the other hand, LY but not CHE or 5HD prevented olprinone-induced reductions of infarct size. CONCLUSIONS:
|
Authors | Shuhei Matsumoto, Sungsam Cho, Shinya Tosaka, Hiroyuki Ureshino, Takuji Maekawa, Tetsuya Hara, Koji Sumikawa |
Journal | Cardiovascular drugs and therapy
(Cardiovasc Drugs Ther)
Vol. 23
Issue 4
Pg. 263-70
(Aug 2009)
ISSN: 1573-7241 [Electronic] United States |
PMID | 19597978
(Publication Type: Comparative Study, Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Anesthetics, Inhalation
- Imidazoles
- Phosphodiesterase Inhibitors
- Potassium Channels
- Pyridones
- mitochondrial K(ATP) channel
- olprinone
- Isoflurane
- Phosphatidylinositol 3-Kinases
- Proto-Oncogene Proteins c-akt
- Protein Kinase C
|
Topics |
- Anesthetics, Inhalation
(pharmacology)
- Animals
- Diabetes Mellitus, Experimental
(complications)
- Diabetes Mellitus, Type 2
(complications)
- Imidazoles
(pharmacology)
- Isoflurane
(pharmacology)
- Male
- Myocardial Infarction
(prevention & control)
- Phosphatidylinositol 3-Kinases
(metabolism)
- Phosphodiesterase Inhibitors
(pharmacology)
- Potassium Channels
(metabolism)
- Protein Kinase C
(metabolism)
- Proto-Oncogene Proteins c-akt
(metabolism)
- Pyridones
(pharmacology)
- Random Allocation
- Rats
- Rats, Inbred Strains
- Rats, Wistar
|